List of Tables
    Table 1. Global Monoclonal Antibodies Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Monoclonal Antibodies Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Monoclonal Antibodies Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Monoclonal Antibodies Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Monoclonal Antibodies Manufacturing Sites and Area Served
    Table 11. Manufacturers Monoclonal Antibodies Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
    Table 16. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Table 17. Global Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
    Table 19. North America Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 20. North America Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 21. North America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 23. Europe Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 25. Europe Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 33. Latin America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 39. Global Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
    Table 40. Global Monoclonal Antibodies Sales Market Share by Type (2017-2022)
    Table 41. Global Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Monoclonal Antibodies Revenue Share by Type (2017-2022)
    Table 43. Global Monoclonal Antibodies Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Monoclonal Antibodies Sales (K Units) by Application (2017-2022)
    Table 45. Global Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Table 46. Global Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Monoclonal Antibodies Revenue Share by Application (2017-2022)
    Table 48. Global Monoclonal Antibodies Price by Application (2017-2022) & (USD/Unit)
    Table 49. Biocon Corporation Information
    Table 50. Biocon Description and Business Overview
    Table 51. Biocon Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Biocon Monoclonal Antibodies Product
    Table 53. Biocon Recent Developments/Updates
    Table 54. Celltrion Corporation Information
    Table 55. Celltrion Description and Business Overview
    Table 56. Celltrion Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Celltrion Monoclonal Antibodies Product
    Table 58. Celltrion Recent Developments/Updates
    Table 59. Dr. Reddy's Laboratories Corporation Information
    Table 60. Dr. Reddy's Laboratories Description and Business Overview
    Table 61. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Dr. Reddy's Laboratories Monoclonal Antibodies Product
    Table 63. Dr. Reddy's Laboratories Recent Developments/Updates
    Table 64. Hospira Corporation Information
    Table 65. Hospira Description and Business Overview
    Table 66. Hospira Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Hospira Monoclonal Antibodies Product
    Table 68. Hospira Recent Developments/Updates
    Table 69. 3SBio Corporation Information
    Table 70. 3SBio Description and Business Overview
    Table 71. 3SBio Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. 3SBio Monoclonal Antibodies Product
    Table 73. 3SBio Recent Developments/Updates
    Table 74. Accord Healthcare Corporation Information
    Table 75. Accord Healthcare Description and Business Overview
    Table 76. Accord Healthcare Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Accord Healthcare Monoclonal Antibodies Product
    Table 78. Accord Healthcare Recent Developments/Updates
    Table 79. AET Biotech Corporation Information
    Table 80. AET Biotech Description and Business Overview
    Table 81. AET Biotech Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. AET Biotech Monoclonal Antibodies Product
    Table 83. AET Biotech Recent Developments/Updates
    Table 84. Allergan Corporation Information
    Table 85. Allergan Description and Business Overview
    Table 86. Allergan Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Allergan Monoclonal Antibodies Product
    Table 88. Allergan Recent Developments/Updates
    Table 89. Amega Biotech Corporation Information
    Table 90. Amega Biotech Description and Business Overview
    Table 91. Amega Biotech Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Amega Biotech Monoclonal Antibodies Product
    Table 93. Amega Biotech Recent Developments/Updates
    Table 94. Production Base and Market Concentration Rate of Raw Material
    Table 95. Key Suppliers of Raw Materials
    Table 96. Monoclonal Antibodies Distributors List
    Table 97. Monoclonal Antibodies Customers List
    Table 98. Monoclonal Antibodies Market Trends
    Table 99. Monoclonal Antibodies Market Drivers
    Table 100. Monoclonal Antibodies Market Challenges
    Table 101. Monoclonal Antibodies Market Restraints
    Table 102. Global Monoclonal Antibodies Sales Forecast by Type (2023-2028) & (K Units)
    Table 103. Global Monoclonal Antibodies Sales Market Share Forecast by Type (2023-2028)
    Table 104. Global Monoclonal Antibodies Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 105. Global Monoclonal Antibodies Revenue Market Share Forecast by Type (2023-2028)
    Table 106. Global Monoclonal Antibodies Sales Forecast by Application (2023-2028) & (K Units)
    Table 107. Global Monoclonal Antibodies Sales Market Share Forecast by Application (2023-2028)
    Table 108. Global Monoclonal Antibodies Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 109. Global Monoclonal Antibodies Revenue Market Share Forecast by Application (2023-2028)
    Table 110. Global Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (K Units)
    Table 111. Global Monoclonal Antibodies Sales Market Share Forecast by Region (2023-2028)
    Table 112. Global Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 113. Global Monoclonal Antibodies Revenue Market Share Forecast by Region (2023-2028)
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Monoclonal Antibodies
    Figure 2. Global Monoclonal Antibodies Market Share by Type in 2021 & 2028
    Figure 3. Erythropoietin (EPO) Product Picture
    Figure 4. Human Growth Hormone (HGH) Product Picture
    Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
    Figure 6. Monoclonal Antibody (mAb) Product Picture
    Figure 7. Insulin Product Picture
    Figure 8. Interferon (IFN) Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Monoclonal Antibodies Market Share by Application in 2021 & 2028
    Figure 11. Anti-Cancer
    Figure 12. Anti-Inflammatory/Autoimmune
    Figure 13. Global Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Monoclonal Antibodies Market Size (2017-2028) & (US$ Million)
    Figure 15. Global Monoclonal Antibodies Sales (2017-2028) & (K Units)
    Figure 16. Monoclonal Antibodies Sales Share by Manufacturers in 2021
    Figure 17. Global Monoclonal Antibodies Revenue Share by Manufacturers in 2021
    Figure 18. The Global 5 and 10 Largest Monoclonal Antibodies Players: Market Share by Revenue in 2021
    Figure 19. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Figure 21. Global Monoclonal Antibodies Sales Market Share by Region in 2021
    Figure 22. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
    Figure 23. Global Monoclonal Antibodies Revenue Market Share by Region in 2021
    Figure 24. U.S. Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Canada Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Germany Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. France Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. U.K. Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Italy Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Russia Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Japan Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. South Korea Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. India Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Australia Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Taiwan Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Indonesia Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Thailand Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Malaysia Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Philippines Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Vietnam Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Mexico Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Brazil Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Argentina Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. U.A.E Monoclonal Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Monoclonal Antibodies by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Monoclonal Antibodies
    Figure 50. Manufacturing Process Analysis of Monoclonal Antibodies
    Figure 51. Monoclonal Antibodies Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed